Literature DB >> 10777478

Endogenous c-N-Ras provides a steady-state anti-apoptotic signal.

J C Wolfman1, A Wolfman.   

Abstract

We report that c-N-Ras possesses an isoform-specific, functional role in cell survival under steady-state conditions. This function includes protection from programmed cell death by serum deprivation or upon treatment with apoptosis-inducing agents. The data demonstrate that c-N-Ras may play a functional role in the regulation of steady-state phosphorylated Akt and serine 136-phosphorylated Bad (Ser(136)-pBad). Immortalized N-Ras knockout fibroblasts possess nearly undetectable levels of steady-state Ser(136)-pBad. In contrast, wild-type control cells and the N-Ras knockout cells ectopically expressing c-N-Ras at control levels maintained easily detectable levels of Ser(136)-pBad both at steady-state and following treatment with tumor necrosis factor alpha. Similar results were seen with Ser(112)-pBad. These differences did not arise from differences in total Bad protein levels. These data correlate with the observation that the N-Ras knockout cells exhibit a heightened susceptibility to the induction of apoptosis. Ectopic expression of c-N-Ras in the N-Ras knockout cells at endogenous levels, compared with control cells, significantly rescues the apoptotically sensitive phenotype. Elevated expression of either c-Kirsten A-Ras or c-Kirsten B-Ras did not reverse the apoptotic sensitivity of the N-Ras knockout cells or result in increased levels of either phospho-Akt or phospho-Bad. Our results indicate that, at steady state, c-N-Ras possesses an isoform-specific, functional role in cell survival.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10777478     DOI: 10.1074/jbc.M000250200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  17 in total

1.  H-Ras signaling and K-Ras signaling are differentially dependent on endocytosis.

Authors:  Sandrine Roy; Bruce Wyse; John F Hancock
Journal:  Mol Cell Biol       Date:  2002-07       Impact factor: 4.272

2.  Distinct utilization of effectors and biological outcomes resulting from site-specific Ras activation: Ras functions in lipid rafts and Golgi complex are dispensable for proliferation and transformation.

Authors:  David Matallanas; Victoria Sanz-Moreno; Imanol Arozarena; Fernando Calvo; Lorena Agudo-Ibáñez; Eugenio Santos; María T Berciano; Piero Crespo
Journal:  Mol Cell Biol       Date:  2006-01       Impact factor: 4.272

3.  Wild-type NRas and KRas perform distinct functions during transformation.

Authors:  Poppy P Fotiadou; Chiaki Takahashi; Hasan N Rajabi; Mark E Ewen
Journal:  Mol Cell Biol       Date:  2007-07-16       Impact factor: 4.272

4.  Ras, an actor on many stages: posttranslational modifications, localization, and site-specified events.

Authors:  Imanol Arozarena; Fernando Calvo; Piero Crespo
Journal:  Genes Cancer       Date:  2011-03

5.  Classic Ras Proteins Promote Proliferation and Survival via Distinct Phosphoproteome Alterations in Neurofibromin-Null Malignant Peripheral Nerve Sheath Tumor Cells.

Authors:  Nicole M Brossier; Amanda M Prechtl; Jody Fromm Longo; Stephen Barnes; Landon S Wilson; Stephanie J Byer; Stephanie N Brosius; Steven L Carroll
Journal:  J Neuropathol Exp Neurol       Date:  2015-06       Impact factor: 3.685

6.  Mutant N-RAS protects colorectal cancer cells from stress-induced apoptosis and contributes to cancer development and progression.

Authors:  Yufang Wang; Sérgia Velho; Efsevia Vakiani; Shouyong Peng; Adam J Bass; Gerald C Chu; Jessica Gierut; James M Bugni; Channing J Der; Mark Philips; David B Solit; Kevin M Haigis
Journal:  Cancer Discov       Date:  2012-12-28       Impact factor: 39.397

7.  Live-cell imaging of endogenous Ras-GTP illustrates predominant Ras activation at the plasma membrane.

Authors:  Martin Augsten; Rico Pusch; Christoph Biskup; Knut Rennert; Ute Wittig; Katja Beyer; Alfred Blume; Reinhard Wetzker; Karlheinz Friedrich; Ignacio Rubio
Journal:  EMBO Rep       Date:  2006-01       Impact factor: 8.807

8.  Ras isoform abundance and signalling in human cancer cell lines.

Authors:  J Omerovic; D E Hammond; M J Clague; I A Prior
Journal:  Oncogene       Date:  2007-11-12       Impact factor: 9.867

9.  Loss of integrin alpha1beta1 ameliorates Kras-induced lung cancer.

Authors:  Ines Macias-Perez; Corina Borza; Xiwu Chen; Xuexian Yan; Raquel Ibanez; Glenda Mernaugh; Lynn M Matrisian; Roy Zent; Ambra Pozzi
Journal:  Cancer Res       Date:  2008-08-01       Impact factor: 12.701

10.  RAS mutations affect tumor necrosis factor-induced apoptosis in colon carcinoma cells via ERK-modulatory negative and positive feedback circuits along with non-ERK pathway effects.

Authors:  Pamela K Kreeger; Roli Mandhana; Shannon K Alford; Kevin M Haigis; Douglas A Lauffenburger
Journal:  Cancer Res       Date:  2009-09-29       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.